A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines

被引：0
|
作者：
Culpin, R. E. [1 ]
Anderson, J. J. [1 ]
Angus, B. [2 ]
Proctor, S. J. [1 ]
Crosier, S. [2 ]
Mainou-Fowler, T. [1 ]
机构：
[1] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[2] Royal Victoria Infirm, Dept Cell Pathol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 149卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
221
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [21] MicroRNA-181a Inhibits Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Progression by Repressing CARD11
    Zhu, Danxia
    Fang, Cheng
    He, Wenting
    Wu, Chen
    Li, Xiaodong
    Wu, Jun
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [22] Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications
    Lenz, Georg
    CANCERS, 2015, 7 (02): : 811 - 822
  • [23] AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity
    Lossos, IS
    Levy, R
    Alizadeh, AA
    LEUKEMIA, 2004, 18 (11) : 1775 - 1779
  • [24] AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity
    I S Lossos
    R Levy
    A A Alizadeh
    Leukemia, 2004, 18 : 1775 - 1779
  • [25] MethotrexateMethotrexate-related lymphoproliferative disorder secondary to non-germinal centre B-cell-like diffuse large B-cell lymphoma: case report
    Reactions Weekly, 2017, 1679 (1) : 113 - 113
  • [26] BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
    Iqbal, J
    Neppalli, VT
    Wright, G
    Dave, LJ
    Horsman, DE
    Rosenwald, A
    Lynch, J
    Hans, CP
    Weisenburger, DD
    Greiner, TC
    Gascoyne, RD
    Campo, E
    Ott, G
    Müller-Hermelink, HK
    Delabie, J
    Jaffe, ES
    Grogan, TM
    Connors, JM
    Vose, JM
    Armitage, JO
    Staudt, LM
    Chan, WC
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) : 961 - 968
  • [27] Bone Marrow Molecular Markers Associated with Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma
    Wang, Di
    Liu, Peng
    Zhang, Yue
    Liu, Hui-Ying
    Shen, Di
    Che, Yi-Qun
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [28] Interleukin-4 distinctively modifies responses of germinal centre-like and activated B-cell-like diffuse large B-cell lymphomas to immuno-chemotherapy
    Sarosiek, Kristopher A.
    Nechushtan, Hovav
    Lu, Xiaoqing
    Rosenblatt, Joseph D.
    Lossos, Izidore S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (03) : 308 - 318
  • [29] Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma
    Pham-Ledard, Anne
    Prochazkova-Carlotti, Martina
    Andrique, Laetitia
    Cappellen, David
    Vergier, Beatrice
    Martinez, Fabian
    Grange, Florent
    Petrella, Tony
    Beylot-Barry, Marie
    Merlio, Jean-Philippe
    MODERN PATHOLOGY, 2014, 27 (03) : 402 - 411
  • [30] Upregulation of Cereblon Expression By the DNA Methyltransferase Inhibitor Azacytidine Strongly Enhances Lenalidomide Cytotoxicity in Germinal Center B-Cell-like (GCB) and Activated B-Cell-like (ABC) Diffuse Large B-Cell Lymphoma (DLBCL)
    Locatelli, Silvia L.
    Papait, Roberto
    Careddu, Giuseppa
    Koschorke, Ada
    Stirparo, Giuliano G.
    Balzarotti, Monica
    Castagna, Luca
    Santoro, Armando
    Carlo-Stella, Carmelo
    BLOOD, 2014, 124 (21)
12345